Predictors of antimalarial treatment failure in an area of unstable malaria transmission in eastern Sudan

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 103, Issue 1, 2009, Pages 21-24

  Adam, Ishag ^a   Elmardi, Khalid A ^b   Malik, Elfatih M ^b  

^a UNIVERSITY OF KHARTOUM   (Sudan)

^b FEDERAL MINISTRY OF HEALTH   (Sudan)

Author keywords

Age factor; Body temperature; Drug resistance; Malaria; Sudan; Treatment failure

Indexed keywords

AMODIAQUINE; ANTIMALARIAL AGENT; ARTESUNATE; CHLOROQUINE; FANSIDAR; MEFLOQUINE; PYRIMETHAMINE; QUININE; SULFALENE;

ADOLESCENT; ARTICLE; CHILD; COMBINATION CHEMOTHERAPY; DISEASE TRANSMISSION; DRUG TREATMENT FAILURE; GAMETOCYTE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MONOTHERAPY; PARASITEMIA; PLASMODIUM FALCIPARUM; PREDICTION; STATISTICAL MODEL; SUDAN; TEMPERATURE;

ADOLESCENT; AGE FACTORS; ANTIMALARIALS; CHILD; CHILD, PRESCHOOL; CHLOROQUINE; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INFANT; MALARIA, FALCIPARUM; MALE; PARASITEMIA; PREDICTIVE VALUE OF TESTS; PYRIMETHAMINE; RISK FACTORS; SUDAN; SULFADOXINE; TREATMENT FAILURE;

PLASMODIUM FALCIPARUM;

EID: 56949084166     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trstmh.2008.07.005     Document Type: Article

References (26)

1. WHO. A global strategy for malaria control (1993), World Health Organization, Geneva
2. Adam I., Osman M.E., El Ghazali G., Ahmed G.I., Gustafson L.L., and Elbashir M.I. Efficacies of chloroquine, sulphadoxine-pyrimethamine and quinine for the treatment of uncomplicated Plasmodium falciparum malaria in Eastern Sudan. Ann Trop Med Parasitol 98 (2004) 661-666
3. WHO. Assessment and monitoring of antimalarial drug efficacy for the treatment of uncomplicated falciparum malaria (2003), World Health Organization, Geneva WHO/HTM/RBM/2003.50
4. Dorsey G., Kamya M.R., Ndeezi G., Babirye J.N., Phares C.R., Olson J.E., et al. Predictors of chloroquine treatment failure in children and adults with falciparum malaria in Kampala, Uganda. Am J Trop Med Hyg 62 (2000) 686-692
5. Dorsey G., Gasasira A.F., Machekano R., Kamya M.R., Staedke S.G., and Hubbard A. The impact of age, temperature, and parasite density on treatment outcomes from antimalarial clinical trials in Kampala, Uganda. Am J Trop Med Hyg 71 (2004) 531-536
6. Sowunmi A., Fateye B.A., Adedeji A.A., Fehintola F.A., Gbotosho G.O., Happi T.C., et al. Predictors of the failure of treatment with chloroquine in children with acute, uncomplicated, Plasmodium falciparum malaria, in an area with high and increasing incidences of chloroquine resistance. Ann Trop Med Parasitol 99 (2005) 535-544
7. Malik E.M., and Khalafalla O.M. Malaria in Sudan: past, present and the future. Gezira J Health Sci 1 Suppl (2004) 47-51
8. Himeidan Y.E., Malik E.M., and Adam I. Epidemiology and seasonal pattern of malaria in an irrigated area of eastern Sudan. Am J Infect Dis 1 (2005) 75-78
9. Ibrahium A.M., Kheir M.M., Osman M.E., Khalil I.F., Alifrangis M., Elmardi K.A., et al. Efficacies of artesunate plus either sulfadoxine-pyrimethamine or amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in eastern Sudan. Ann Trop Med Parasitol 101 (2007) 15-21
10. Elamin S.B., Malik E.M., Abdelgadir T., Khamiss A.H., Mohammed M.M., Ahmed E.S., et al. Artesunate plus sulfadoxine-pyrimethamine for treatment of uncomplicated Plasmodium falciparum malaria in Sudan. Malar J 4 (2005) 41
11. Adam I., Salih I., and Elbashir M.I. Quinine for the treatment of uncomplicated Plasmodium falciparum malaria in eastern Sudan. Trans R Soc Trop Med Hyg 99 (2005) 736-738
12. Adam I., A-Elbasit I.E., Idris S.M., Malik E.M., and Elbashir M.I. A comparison of the efficacy of artesunate plus sulfadoxine-pyrimethamine with that of sulfadoxine-pyrimethamine alone, in the treatment of uncomplicated, Plasmodium falciparum malaria in eastern Sudan. Ann Trop Med Parasitol 99 (2005) 449-455
13. Adam I., A-Elbasit I.E., and Elbashir M.I. Efficacies of mefloquine alone and of artesunate followed by mefloquine, for the treatment of uncomplicated, Plasmodium falciparum malaria in eastern Sudan. Ann Trop Med Parasitol 99 (2005) 111-117
14. Adam I., Magzoub M., Osman M.E., Khalil I.F., Alifrangis M., and Elmardi K.A. A fixed-dose 24-hour regimen of artesunate plus sulfamethoxypyrazine-pyrimethamine for the treatment of uncomplicated Plasmodium falciparum malaria in eastern Sudan. Ann Clin Microbiol Antimicrob 5 (2006) 18
15. Salah M.T., Mohammed M.M., Himeidan Y.E., Malik E.M., Elbashir M.I., and Adam I. A randomized comparison of sulphadoxine-pyrimethamine and combination of sulphadoxine pyrimethamine with chloroquine in the treatment of uncomplicated falciparum malaria in Eastern Sudan. Saudi Med J 26 (2005) 147-148
16. WHO. Assessment of therapeutic efficacy of antimalarial drugs for uncomplicated falciparum malaria in areas with intense transmission (1996), World Health Organization, Geneva WHO/MAL/96.1077
17. Fontanet A.L., and Walker A.M. Predictors of treatment failure in multiple drug-resistant falciparum malaria: results from a 42-day follow-up of 224 patients in eastern Thailand. Am J Trop Med Hyg 49 (1993) 465-472
18. Ter Kuile F.O., Luxemburger C., Nosten F., Thwai K.L., Chongsuphajaisiddhi T., and White N.J. Predictors of mefloquine treatment failure: a prospective study of 1590 patients with uncomplicated falciparum malaria. Trans R Soc Trop Med Hyg 89 (1995) 660-664
19. Sowunmi A., Fateye B.A., Adedeji A.A., Fehintola F.A., Gbotosho G.O., Happi T.C., et al. Predictors of the failure of treatment with chloroquine plus chlorpheniramine, in children with acute, uncomplicated, Plasmodium falciparum malaria. Ann Trop Med Parasitol 99 (2005) 331-338
20. Sowunmi A., Gbotosho G.O., Fateye B.A., and Adedeji A.A. Predictors of the failure of treatment with trimethoprim-sulfamethoxazole in children with uncomplicated, Plasmodium falciparum malaria. Ann Trop Med Parasitol 100 (2006) 205-211
21. Rogier C., Tall A., Diagne N., Fontenille D., Spiegel A., and Trape J.F. Plasmodium falciparum clinical malaria: lessons from longitudinal studies in Senegal. Parassitologia 41 (1999) 255-259
22. Singhasivanon V., Chongsuphajaisiddhi T., Sabcharoen A., Attanath P., Webster H.K., Wernsdorfer W.H., et al. Pharmacokinetics of mefloquine in children aged 6 to 24 months. Eur J Drug Metab Pharmacokinet 17 (1992) 275-279
23. White N.J. Assessment of the pharmacodynamic properties of antimalarial drugs in vivo. Antimicrob Agents Chemother 41 (1997) 1413-1422
24. Hoffmann E.H., da Silveira L.A., Tonhosolo R., Pereira F.J., Ribeiro W.L., Tonon A.P., et al. Geographical patterns of allelic diversity in the Plasmodium falciparum malaria-vaccine candidate, merozoite surface protein-2. Ann Trop Med Parasitol 95 (2001) 117-132
25. Adam I., A-Elbasit I.E., Salih I., and Elbashir M.I. Submicroscopic Plasmodium falciparum infections during pregnancy, in an area of Sudan with a low intensity of malaria transmission. Ann Trop Med Parasitol 99 (2005) 339-344
26. Hamer D.H., MacLeod W.B., Addo-Yobo E., Duggan C.P., Estrella B., Fawzi W.W., et al. Age, temperature, and parasitaemia predict chloroquine treatment failure and anaemia in children with uncomplicated Plasmodium falciparum malaria. Trans R Soc Trop Med Hyg 97 (2003) 422-428